Biosimilars in rheumatoid arthritis in 2022 – data from the Romanian Registry of Rheumatic Diseases
Objective. The study aimed at determining whether RA patients starting or stopping biosimilars differ in any regard from those starting or stopping originals. Methods. Data on RA patients was obtained from the Romanian Registry of Rheumatic Diseases (RRBR) database between January 1st, 2022, and Dec...
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Amaltea Medical Publishing House
2023-09-01
|
| 丛编: | Romanian Journal of Rheumatology |
| 主题: | |
| 在线阅读: | https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-06.pdf |